Results

1–10 of 21 results for Panretinal Photocoagulation

Aflibercept Versus Vitrectomy With Panretinal Photocoagulation for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Hani Salehi-Had, MD
On Demand Cases, Courses, and Papers
2021
Comparing Rates of Vitrectomy in Proliferative Diabetic Retinopathy Patients Treated With Anti-VEGF or Panretinal Photocoagulation Monotherapy
Nadim M Rayess, MD
Annual Meeting Talks
2021
Outcomes of Treatment-naïve Eyes With Proliferative Diabetic Retinopathy Treated With Navigated Laser (NAVILAS) Pan-retinal Photocoagulation
Pradeep Satya Prasad, MD, MBA
On Demand Cases, Courses, and Papers
2020
Trends in the treatment of proliferative diabetic retinopathy before and after the Diabetic Retinopathy Clinical Research Network Protocol S study
John W Hinkle, MD
Updates from the Field
2020
Factors Predicting Vitreous Hemorrhage or Neovascularization after Pan-Retinal Photocoagulation in Proliferative Diabetic Retinopathy
Jose Davila, MD
Updates from the Field
2020
Economic Impact of the Use of Anti-VEGF Monotherapy or in Combination With Panretinal Photocoagulation in the Treatment of Retinopathy of Prematurity
Swati Agarwal-Sinha, MD, FASRS
Updates from the Field
2019
Economic Impact of the Use of Anti-VEGF Monotherapy or in Combination With Panretinal Photocoagulation
Swati Agarwal-Sinha, MD, FASRS
Annual Meeting Talks
PDR; High Myopia; PRP
Carissa Hurdstrom
Retina Image Bank: Images of the Week
Outcomes in Proliferative Diabetic Retinopathy Patients Lost to Follow-up After Panretinal Photocoagulation Versus Antivascular Endothelial Growth Factor
Daniel Su, MD
Annual Meeting Talks
2018
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Should Baseline Characteristics Affect Choice of Treatment?
Susan B. Bressler, MD, FASRS
Annual Meeting Talks
2018